Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Operating Profit Margin
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abiomed Inc., operating profit margin, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).

1 US$ in thousands


Income (loss) from operations
The operational income exhibits considerable variability over the observed period. Initially, the company experienced consistent operational losses from 2005 through 2010, with figures worsening up to a loss of approximately $30.3 million in 2006. From 2011 onwards, a notable turnaround occurs, with the company generating positive operating income beginning in 2012. This positive trend continues sharply, peaking at around $249.2 million in 2020, before slightly declining to approximately $140.7 million by 2022. Overall, the data reflects a transition from sustained losses toward solid operational profitability in later years.
Revenue
Revenue has shown steady and substantial growth throughout the time frame. Starting at about $38.2 million in 2005, the revenue increased almost continuously year-over-year, reaching over $1 billion by 2022. This growth is particularly pronounced from 2012 onwards, during which annual revenue more than quadrupled, indicating strong top-line expansion and possibly market penetration or product/service growth.
Operating profit margin
The operating profit margin mirrors the trends seen in operational income. Initially negative for many years—reaching its lowest point at nearly -69.4% in 2006—the margin starts to improve around 2011. Margins then become positive by 2012 and continue to increase, peaking above 29% in 2020 and 2021. However, a decline to approximately 13.6% by 2022 is observed, suggesting either increased operational costs or other factors impacting profitability. Despite the recent decline, the margin performance post-2011 indicates a marked improvement in operational efficiency and profitability relative to revenue.

Comparison to Competitors

Abiomed Inc., operating profit margin, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31), 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31), 10-K (reporting date: 2010-03-31), 10-K (reporting date: 2009-03-31), 10-K (reporting date: 2008-03-31), 10-K (reporting date: 2007-03-31), 10-K (reporting date: 2006-03-31), 10-K (reporting date: 2005-03-31).